Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Clear-cell metastatic renal cell carcinoma × sitravatinib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Advanced Malignancies 1

Interventions

cabozantinib 3 Nivolumab 3 Specimen Handling 2 sitravatinib 1 lenvatinib 1 Tissue Banks 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Everolimus 1 CTLA-4 Antigen 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04904302 2026-03-16

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡